Can gut bacteria help treat peanut allergy?

If you live with a peanut allergy, you probably don’t need another reminder to read labels. You already know how quickly an ordinary meal can turn into a calculation: What’s in the sauce? Was the same equipment used for another dish? Is my epinephrine with me?

That’s why a study about changing the gut microbiome caught my attention. The question is interesting: could the bacteria living in our intestines influence how strongly the immune system reacts to peanut?

What did the study actually do?

Researchers enrolled 15 adults with peanut allergy. Each received capsules containing gut microbes from carefully screened donors. Ten took the capsules alone; five took antibiotics first, with the aim of making room for the donor microbes to establish themselves.

Before and after treatment, participants ate measured amounts of peanut during supervised food challenges. This gave researchers a way to see whether it took more peanut to trigger a reaction. It was done in a medical setting because peanut challenges can cause serious reactions.

Three of the ten people who took the capsules alone, and three of the five who took antibiotics first, could tolerate more peanut afterward. That is six people in total. It’s a result worth studying further, but the two groups are far too small to conclude that antibiotics improved the treatment.

Why would gut bacteria affect an allergy?

The gut does more than digest food. It’s also a place where microbes and immune cells interact constantly. Researchers found that the people who responded to treatment had changes in immune cells involved in allergic reactions. They also found changes in bile acid metabolites, substances influenced by gut bacteria.

Those findings offer a possible explanation for how the treatment worked. They don’t yet tell us which microbes matter most, whether the same changes would occur in other patients, or how to turn them into a dependable treatment. That distinction is important. A clue about the biology is valuable, but it isn’t a prescription.

What’s the catch?

This was an early study of 15 adults, and everyone received the treatment. Without a comparison group, we need to be careful about how much we attribute to the capsules. We also need larger studies to learn whether an increase in tolerance lasts and whether it meaningfully reduces the risk from accidental exposure.

Most of all, a higher reaction threshold is not the same as being free of a peanut allergy. Someone who reacts to a larger amount of peanut may still have a dangerous reaction. Nobody should use these results to test their limits at home.

What would I tell a patient right now?

I’d say this is promising research, and I’d understand why you’re interested. I’d also tell you to stick with the allergy plan you have today. Continue the precautions you and your allergist have discussed, and keep prescribed epinephrine available.

Gut microbe transplants are still being studied for peanut allergy. If you want to know whether a clinical trial might be an option, bring this study to your allergist. That’s a useful conversation to have. It just shouldn’t start with changing your safety plan on your own.